Maj Invest Holding A S Increases Stock Holdings in HCA Healthcare, Inc. $HCA

Maj Invest Holding A S increased its stake in HCA Healthcare, Inc. (NYSE:HCA) by 34.8% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 232,486 shares of the company’s stock after acquiring an additional 60,011 shares during the quarter. HCA Healthcare makes up about 4.1% of Maj Invest Holding A S’s portfolio, making the stock its 15th biggest holding. Maj Invest Holding A S’s holdings in HCA Healthcare were worth $90,645,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also modified their holdings of the company. Brighton Jones LLC acquired a new stake in HCA Healthcare in the 4th quarter worth about $1,021,000. NewEdge Advisors LLC boosted its stake in shares of HCA Healthcare by 11.9% in the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after acquiring an additional 409 shares during the last quarter. Sivia Capital Partners LLC raised its stake in HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after purchasing an additional 33 shares during the last quarter. Jump Financial LLC acquired a new stake in HCA Healthcare during the 2nd quarter worth $2,073,000. Finally, Sei Investments Co. raised its position in shares of HCA Healthcare by 56.3% in the second quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock valued at $52,328,000 after buying an additional 49,214 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

HCA stock opened at $412.80 on Friday. The firm’s 50 day moving average price is $389.00 and its 200-day moving average price is $448.75. The firm has a market cap of $89.37 billion, a PE ratio of 13.82, a PEG ratio of 1.44 and a beta of 1.10. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. The company had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.84 earnings per share. Equities research analysts predict that HCA Healthcare, Inc. will post 29.45 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 10.45%.

Analyst Ratings Changes

HCA has been the subject of several research reports. JPMorgan Chase & Co. dropped their price objective on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a research note on Tuesday, May 19th. Wells Fargo & Company boosted their target price on HCA Healthcare from $369.00 to $381.00 and gave the stock an “equal weight” rating in a report on Monday, August 3rd. Leerink Partners cut their price target on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Mizuho dropped their target price on HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating for the company in a report on Tuesday, July 28th. Finally, Royal Bank Of Canada reiterated an “outperform” rating and set a $435.00 price target on shares of HCA Healthcare in a report on Monday, July 27th. Fourteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $465.59.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.